▶ 調査レポート

脊椎イメージングのグローバル市場(~2027):CT、MRI、超音波検査、X線

• 英文タイトル:Spinal Imaging Market Research Report by Product, Application, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Spinal Imaging Market Research Report by Product, Application, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「脊椎イメージングのグローバル市場(~2027):CT、MRI、超音波検査、X線」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2303E127
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、258ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥732,452 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,472,452 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の本調査資料は、2021年に1,981.00百万ドルであった世界の脊椎イメージング市場規模が、2022年に2,218.32百万ドルになり、2027年まで年平均12.23%で成長して3,959.61百万ドルに到達すると予想しています。本レポートでは、脊椎イメージングの世界市場を広く調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別(CT、MRI、超音波検査、X線)分析、用途別(脊椎癌、脊髄&神経圧迫、脊椎感染症、椎体骨折)分析、エンドユーザー別(外来診療所、画像診断センター、病院)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などの項目を掲載しています。また、参入企業情報として、3M Company、7D Surgical Systems、ATEC Spine, Inc、Becton, Dickinson & Company、Bruker Corporation、Canon Medical Systems Corporation、FUJIFILM Corporation、GE Healthcare Inc.、GPC Medical Ltd、Hitachi, Ltd.、Invibio Ltd.、Koninklijke Philips N.V.、Medtronic PLC、Narang Medical Limited、Novartis AGなどが含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の脊椎イメージング市場規模:製品別
- CTの市場規模
- MRIの市場規模
- 超音波検査の市場規模
- X線の市場規模
・世界の脊椎イメージング市場規模:用途別
- 脊椎癌における市場規模
- 脊髄&神経圧迫における市場規模
- 脊椎感染症における市場規模
- 椎体骨折における市場規模
・世界の脊椎イメージング市場規模:エンドユーザー別
- 外来診療所における市場規模
- 画像診断センターにおける市場規模
- 病院における市場規模
・世界の脊椎イメージング市場規模:地域別
- 南北アメリカの脊椎イメージング市場規模
アメリカの脊椎イメージング市場規模
カナダの脊椎イメージング市場規模
ブラジルの脊椎イメージング市場規模
...
- アジア太平洋の脊椎イメージング市場規模
日本の脊椎イメージング市場規模
中国の脊椎イメージング市場規模
インドの脊椎イメージング市場規模
韓国の脊椎イメージング市場規模
台湾の脊椎イメージング市場規模
...
-ヨーロッパ/中東/アフリカの脊椎イメージング市場規模
イギリスの脊椎イメージング市場規模
ドイツの脊椎イメージング市場規模
フランスの脊椎イメージング市場規模
ロシアの脊椎イメージング市場規模
...
-その他地域の脊椎イメージング市場規模
・競争状況
・企業情報

The Global Spinal Imaging Market size was estimated at USD 1,981.00 million in 2021 and expected to reach USD 2,218.32 million in 2022, and is projected to grow at a CAGR 12.23% to reach USD 3,959.61 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Spinal Imaging to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across CT, MRI, Ultrasound, and X-ray. The CT is further studied across Discogram, Myelogram, and X-ray (without contrast media). The X-ray is further studied across Discogram, Myelogram, and X-ray (without contrast media).

Based on Application, the market was studied across Spinal Cancer, Spinal Cord & Nerve Compressions, Spinal Infection, and Vertebral Fractures.

Based on End-user, the market was studied across Ambulatory care center, Diagnostic imaging center, and Hospitals.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Spinal Imaging market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Spinal Imaging Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Spinal Imaging Market, including 3M Company, 7D Surgical Systems, ATEC Spine, Inc, Becton, Dickinson & Company, Bruker Corporation, Canon Medical Systems Corporation, FUJIFILM Corporation, GE Healthcare Inc., GPC Medical Ltd, Hitachi, Ltd., Invibio Ltd., Koninklijke Philips N.V., Medtronic PLC, Narang Medical Limited, Novartis AG, NuVasive, Inc., Sanofi S.A., Shimadzu Corporation, Siemens Healthineers AG, and Sulzer AG.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Spinal Imaging Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Spinal Imaging Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Spinal Imaging Market?
4. What is the competitive strategic window for opportunities in the Global Spinal Imaging Market?
5. What are the technology trends and regulatory frameworks in the Global Spinal Imaging Market?
6. What is the market share of the leading vendors in the Global Spinal Imaging Market?
7. What modes and strategic moves are considered suitable for entering the Global Spinal Imaging Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing spinal cord injuries throughout the world
5.1.1.2. Growing number of surgeries among target population
5.1.1.3. Rising enhancement to patient accessibility for medical imaging services
5.1.2. Restraints
5.1.2.1. High cost of spinal imaging equipment
5.1.3. Opportunities
5.1.3.1. Recent advancements in hardware and software technology
5.1.3.2. Emerging utilization of machine learning concepts in spinal imaging
5.1.4. Challenges
5.1.4.1. Probable risks and side effects of imaging techniques
5.2. Cumulative Impact of COVID-19

6. Spinal Imaging Market, by Product
6.1. Introduction
6.2. CT
6.3.1. Discogram
6.3.2. Myelogram
6.3.3. X-ray (without contrast media)
6.3. MRI
6.4. Ultrasound
6.5. X-ray
6.6.1. Discogram
6.6.2. Myelogram
6.6.3. X-ray (without contrast media)

7. Spinal Imaging Market, by Application
7.1. Introduction
7.2. Spinal Cancer
7.3. Spinal Cord & Nerve Compressions
7.4. Spinal Infection
7.5. Vertebral Fractures

8. Spinal Imaging Market, by End-user
8.1. Introduction
8.2. Ambulatory care center
8.3. Diagnostic imaging center
8.4. Hospitals

9. Americas Spinal Imaging Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Spinal Imaging Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Spinal Imaging Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. 3M Company
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. 7D Surgical Systems
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. ATEC Spine, Inc
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Becton, Dickinson & Company
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Bruker Corporation
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Canon Medical Systems Corporation
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. FUJIFILM Corporation
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. GE Healthcare Inc.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. GPC Medical Ltd
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Hitachi, Ltd.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Invibio Ltd.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Koninklijke Philips N.V.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Medtronic PLC
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Narang Medical Limited
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Novartis AG
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. NuVasive, Inc.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Sanofi S.A.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Shimadzu Corporation
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Siemens Healthineers AG
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Sulzer AG
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing